Resonance Health Past Earnings Performance
Past criteria checks 0/6
Resonance Health's earnings have been declining at an average annual rate of -49.1%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 6.7% per year.
Key information
-49.1%
Earnings growth rate
-49.1%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 6.7% |
| Return on equity | -11.0% |
| Net Margin | -19.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
We're Interested To See How Resonance Health (ASX:RHT) Uses Its Cash Hoard To Grow
Mar 12
Resonance Health (ASX:RHT) Is In A Good Position To Deliver On Growth Plans
Aug 19Are Robust Financials Driving The Recent Rally In Resonance Health Limited's (ASX:RHT) Stock?
Mar 01If You Had Bought Resonance Health (ASX:RHT) Stock Three Years Ago, You Could Pocket A 855% Gain Today
Jan 15How Does Resonance Health's (ASX:RHT) CEO Salary Compare to Peers?
Nov 22Revenue & Expenses BreakdownBeta
How Resonance Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 6 | -1 | 5 | 1 |
| 30 Sep 23 | 5 | -1 | 5 | 1 |
| 30 Jun 23 | 4 | -1 | 4 | 1 |
| 31 Mar 23 | 4 | -1 | 4 | 1 |
| 31 Dec 22 | 4 | -1 | 4 | 1 |
| 30 Sep 22 | 4 | -1 | 4 | 1 |
| 30 Jun 22 | 4 | -1 | 4 | 1 |
| 31 Mar 22 | 4 | -1 | 3 | 1 |
| 31 Dec 21 | 4 | 0 | 3 | 0 |
| 30 Sep 21 | 4 | 0 | 3 | 0 |
| 30 Jun 21 | 4 | 1 | 2 | 0 |
| 31 Mar 21 | 4 | 1 | 2 | 0 |
| 31 Dec 20 | 4 | 1 | 2 | 0 |
| 30 Sep 20 | 4 | 0 | 3 | 0 |
| 30 Jun 20 | 4 | -1 | 4 | 0 |
| 31 Mar 20 | 4 | -1 | 4 | 0 |
| 31 Dec 19 | 4 | -1 | 4 | 0 |
| 30 Sep 19 | 4 | 0 | 3 | 0 |
| 30 Jun 19 | 4 | 1 | 2 | 0 |
| 31 Mar 19 | 4 | 1 | 2 | 0 |
| 31 Dec 18 | 3 | 1 | 2 | 0 |
| 30 Sep 18 | 3 | 1 | 2 | 0 |
| 30 Jun 18 | 3 | 0 | 2 | 0 |
| 31 Mar 18 | 3 | 0 | 3 | 0 |
| 31 Dec 17 | 3 | 0 | 3 | 0 |
| 30 Sep 17 | 3 | 0 | 2 | 0 |
| 30 Jun 17 | 3 | 0 | 2 | 0 |
| 31 Mar 17 | 3 | 0 | 2 | 0 |
| 31 Dec 16 | 3 | 0 | 2 | 0 |
| 30 Sep 16 | 3 | 0 | 2 | 0 |
| 30 Jun 16 | 3 | 0 | 2 | 0 |
| 31 Mar 16 | 3 | 0 | 2 | 0 |
| 31 Dec 15 | 3 | 0 | 2 | 0 |
| 30 Sep 15 | 3 | 0 | 2 | 0 |
| 30 Jun 15 | 3 | 0 | 2 | 0 |
| 31 Mar 15 | 3 | 0 | 2 | 0 |
| 31 Dec 14 | 2 | 1 | 2 | 0 |
| 30 Sep 14 | 2 | 0 | 2 | 0 |
| 30 Jun 14 | 2 | 0 | 2 | 0 |
| 31 Mar 14 | 2 | 0 | 2 | 0 |
| 31 Dec 13 | 2 | 0 | 2 | 0 |
| 30 Sep 13 | 2 | 0 | 2 | 0 |
| 30 Jun 13 | 2 | 0 | 2 | 0 |
Quality Earnings: RHT is currently unprofitable.
Growing Profit Margin: RHT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RHT is unprofitable, and losses have increased over the past 5 years at a rate of 49.1% per year.
Accelerating Growth: Unable to compare RHT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RHT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: RHT has a negative Return on Equity (-11.04%), as it is currently unprofitable.